Preclinical Characterization of TP-0903, a Novel Multikinase Inhibitor, in TP53 Mutant Acute Myeloid Leukemia

Eisenmann, E; Fobare, S; Huang, K; Jeon, JY; Weber, R; Silvaroli, J; Larsen, B; Stromatt, J; Buelow, D; Orwick, S; Hertlein, E; Byrd, J; Baker, S

FASEB JOURNAL, 2021; 35 ():